These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8994535)

  • 1. Nebulised antipseudomonal therapy in cystic fibrosis.
    Touw DJ; Bakker W
    Thorax; 1996 Dec; 51(12):1283. PubMed ID: 8994535
    [No Abstract]   [Full Text] [Related]  

  • 2. Antipseudomonal antibiotics and cystic fibrosis.
    Henry RL
    Aust N Z J Med; 1999 Feb; 29(1):5-7. PubMed ID: 10200806
    [No Abstract]   [Full Text] [Related]  

  • 3. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis: a meta-analysis of benefits and risks.
    Mukhopadhyay S; Singh M; Cater JI; Ogston S; Franklin M; Olver RE
    Thorax; 1996 Apr; 51(4):364-8. PubMed ID: 8733486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nebulised antipseudomonal antibiotic therapy in cystic fibrosis.
    Hoekstra MO; van Aalderen WM
    Thorax; 1997 Apr; 52(4):398-9. PubMed ID: 9196534
    [No Abstract]   [Full Text] [Related]  

  • 5. Evidence for using nebulised antibiotics in cystic fibrosis.
    Conway SP
    Arch Dis Child; 1999 Apr; 80(4):307-9. PubMed ID: 10086931
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled tobramycin (TOBI): a review of its use in the management of Pseudomonas aeruginosa infections in patients with cystic fibrosis.
    Cheer SM; Waugh J; Noble S
    Drugs; 2003; 63(22):2501-20. PubMed ID: 14609360
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin inhalation solution (Bethkis) for cystic fibrosis.
    Med Lett Drugs Ther; 2014 Jun; 56(1445):51-2. PubMed ID: 24956309
    [No Abstract]   [Full Text] [Related]  

  • 8. TOBI Podhaler for cystic fibrosis patients with Pseudomonas aeruginosa.
    Farinde A
    Nurse Pract; 2015 Jul; 40(7):16-7. PubMed ID: 26080292
    [No Abstract]   [Full Text] [Related]  

  • 9. [How should chronic Pseudomonas aeruginosa bronchial infection be treated in the course of cystic fibrosis?].
    Hubert D; Desmazes-Dufeu N; Dusser D
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S129-35. PubMed ID: 12910145
    [No Abstract]   [Full Text] [Related]  

  • 10. Tobramycin therapy of pulmonary infections in patients with cystic fibrosis.
    Hawley HB; Lewis RM; Swartz DR; Gump DW
    Curr Ther Res Clin Exp; 1974 May; 16(5):414-23. PubMed ID: 4209057
    [No Abstract]   [Full Text] [Related]  

  • 11. Cystic fibrosis upper airways primary colonization with Pseudomonas aeruginosa: eradicated by sinonasal antibiotic inhalation.
    Mainz JG; Michl R; Pfister W; Beck JF
    Am J Respir Crit Care Med; 2011 Nov; 184(9):1089-90. PubMed ID: 22045752
    [No Abstract]   [Full Text] [Related]  

  • 12. Spaced administration of antibiotic combinations to eliminate pseudomonas from sputum in cystic fibrosis.
    Guggenbichler JP; Allerberger F; Dierich MP; Schmitzberger R; Semenitz E
    Lancet; 1988 Sep; 2(8613):749-50. PubMed ID: 2901603
    [No Abstract]   [Full Text] [Related]  

  • 13. The treatment of respiratory pseudomonas infection in cystic fibrosis: what drug and which way?
    Banerjee D; Stableforth D
    Drugs; 2000 Nov; 60(5):1053-64. PubMed ID: 11129122
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimicrobials in cystic fibrosis: emergence of resistance and implications for treatment.
    Zabner R; Quinn JP
    Semin Respir Infect; 1992 Sep; 7(3):210-7. PubMed ID: 1475544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A ten year review of colomycin.
    Littlewood JM; Koch C; Lambert PA; Høiby N; Elborn JS; Conway SP; Dinwiddie R; Duncan-Skingle F
    Respir Med; 2000 Jul; 94(7):632-40. PubMed ID: 10926333
    [No Abstract]   [Full Text] [Related]  

  • 16. Nebulised anti-pseudomonal antibiotics for cystic fibrosis.
    Ryan G; Mukhopadhyay S; Singh M
    Cochrane Database Syst Rev; 2000; (2):CD001021. PubMed ID: 10796732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Strategy of antibiotic therapy in the course of chronic Pseudomonas aeruginosa infection].
    Bassinet L
    Rev Mal Respir; 2003 Apr; 20(2 Pt 2):S118-28. PubMed ID: 12910144
    [No Abstract]   [Full Text] [Related]  

  • 18. Maintenance of Pseudomonas antibiotic sensitivity in patients with cystic fibrosis treated with inhaled antibiotics.
    Wittenberg DF
    S Afr Med J; 1987 Mar; 71(5):335-6. PubMed ID: 3563765
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-Term Inhaled Antipseudomonal Antibiotics in Cystic Fibrosis.
    Greenslade R
    Am J Nurs; 2019 Oct; 119(10):49. PubMed ID: 31567255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of β-lactams as single agents for treating severe pulmonary exacerbations during pregnancy in cystic fibrosis.
    Prickett M; Jain M
    Am J Respir Crit Care Med; 2012 Dec; 186(12):1310-1. PubMed ID: 23250504
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.